Artiva Biotherapeutics, Inc.
ARTV
$2.47
$0.020.82%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 03/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 140.91% | -- | -- | -39.40% | -31.81% |
| Total Receivables | -67.04% | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 150.19% | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 136.32% | -- | -- | -- | -- |
|
|
|||||
| Total Current Assets | 136.32% | -- | -- | -- | -- |
| Net Property, Plant & Equipment | -17.12% | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -19.23% | -- | -- | -- | -- |
| Total Assets | 99.38% | -- | -- | -- | -- |
|
|
|||||
| Total Accounts Payable | 82.57% | -- | -- | -- | -- |
| Total Accrued Expenses | -7.80% | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.00% | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 0.21% | -- | -- | -- | -- |
|
|
|||||
| Total Current Liabilities | 0.21% | -- | -- | -- | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -20.29% | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -99.71% | -- | -- | -- | -- |
| Total Liabilities | -54.77% | -- | -- | -- | -- |
|
|
|||||
| Common Stock & APIC | 2,182.78% | -- | -- | -- | -- |
| Retained Earnings | -36.06% | -- | -- | -- | -- |
| Treasury Stock & Other | -141.88% | -- | -- | -- | -- |
| Total Common Equity | 215.20% | -- | -- | -24.15% | -41.53% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | 215.20% | -- | -- | -24.15% | -41.53% |
| Total Preferred Equity | -- | -- | -- | 0.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 243.10% | -- | -- | -44.87% | -35.29% |
|
|
|||||